Teva Pharmaceutical Industries Limited (BVMF:T1EV34)

BVMF:T1EV34 Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	156,937	154,662	56,786	53,548	49,226	54,924
Market Cap Growth	32.04%	172.36%	6.05%	8.78%	-10.37%	27.67%
Enterprise Value	235,802	255,321	147,189	160,052	177,988	186,130
Last Close Price	67.62	69.28	25.43	23.88	-	-
PE Ratio	41.30	-	-	-	21.19	-
PS Ratio	1.76	1.51	0.74	0.68	0.56	0.64
PB Ratio	4.06	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	50.95	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	27.62	20.05	8.56	6.37	11.07	8.70
EV/Sales Ratio	2.65	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	9.44	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	12.49	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	76.55	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.36	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.62	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	29.57	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.30	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.52	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.11	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	9.71%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.45%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Capital (ROIC)	8.90%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	2.42%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	1.96%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.